Baxter International Inc. BAX
23.37
(0.11)
(0.47%)
as of 25 Sep
- Market cap
- $12.2B
- P/E
- 0.0×
Follow BAX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Baxter International Inc. (BAX) Shares outstanding
Baxter International Inc.'s shares outstanding at the end of fiscal 2025 was $513.0M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $518.0M. Over the past ten years it has ranged from $504.0M (fiscal 2022) to $555.0M (fiscal 2017); the current reading is higher than 45% of that period. Baxter International Inc. ranks 3rd of 51 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Annual
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $513.0M | 0.59% |
| FY2024 | $510.0M | 0.39% |
| FY2023 | $508.0M | 0.79% |
| FY2022 | $504.0M | (0.79%) |
| FY2021 | $508.0M | (1.74%) |
| FY2020 | $517.0M | (0.39%) |
| FY2019 | $519.0M | (4.95%) |
| FY2018 | $546.0M | (1.62%) |
| FY2017 | $555.0M | 0.73% |
| FY2016 | $551.0M | 0.36% |
Quarterly
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $518.0M | 0.58% |
| Mar 2026 | $515.0M | 0.39% |
| Dec 2025 | $513.0M | (0.19%) |
| Sep 2025 | $514.0M | 0.00% |
| 42 more quarters | Free account |
Against its own ten years
Low $504.0M
High $555.0M
Ten-year median
$517.0M
Current reading's percentile
45
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. compare | $677.2M |
| BAX Baxter International Inc. | $518.0M |
| BLCO Bausch + Lomb Corporation compare | $357.1M |
| STVN Stevanato Group S.p.A. compare | $273.0M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $173.3M |
| ALGN Align Technology, Inc. compare | $71.5M |
| ATR AptarGroup, Inc. compare | $64.2M |
| RGEN Repligen Corporation compare | $56.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on BAX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- The full statement